Efficacy and safety of ertugliflozin in patients with type 2 diabetes mellitus and established cardiovascular disease using insulin: A VERTIS CV substudy

AIM: To assess the efficacy and safety of ertugliflozin in patients with type 2 diabetes mellitus (T2DM) and established atherosclerotic cardiovascular disease (ASCVD) inadequately controlled by insulin. MATERIALS AND METHODS: VERTIS CV was the cardiovascular outcome study for ertugliflozin. Patient...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Diabetes Obes Metab
Hauptverfasser: Lingvay, Ildiko, Greenberg, Michelle, Gallo, Silvina, Shi, Harry, Liu, Jie, Gantz, Ira
Format: Artigo
Sprache:Inglês
Veröffentlicht: Blackwell Publishing Ltd 2021
Schlagworte:
Original Articles
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC8252001/
https://ncbi.nlm.nih.gov/pubmed/33769675
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/dom.14385
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge